Method for detecting residual solvent in ginsenoside
The method of detecting residual solvents in ginsenosides by gas chromatography has solved the problem of poor detection accuracy and precision in the prior art, and the accurate detection of three solvents in ginsenosides has been achieved, which has improved the safety and effectiveness of the drug. .
Patent Information
- Application Number
- CN202411066400.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-05
- Publication Date
- 2024-11-12
AI Technical Summary
The prior art cannot accurately detect solvents such as n-butanol, n-hexane and ethyl acetate in ginseng saponins at the same time, resulting in poor detection accuracy and precision, poor resolution, low reproducibility, and affecting the safety of the drug.
The residual solvent in ginseng saponin was detected by gas chromatography. By preparing the reference and test sample solutions, using DB-624 chromatography column and FID detector, appropriate temperature and flow rate conditions were set, headspace injection and chromatography analysis were performed. , calculate the peak area of the solvent to determine its content to ensure detection accuracy and precision.
The simultaneous detection of three residual organic solvents in ginseng saponin has been achieved, which improves detection accuracy, precision and reproducibility, meets the requirements of relevant standards, reduces the adverse effects of residual solvents on drugs, and improves the safety of drugs. Sex and effectiveness.
Smart Images

Figure CN118937542A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of analytical chemistry, and particularly relates to a method for detecting residual solvents in ginsenosides. Background Art
[0002] Ginsenosides are the main active ingredients in ginseng and related medicinal materials of the Araliaceae family. They belong to the triterpenoid steroid compounds and have multiple pharmacological effects, including neuroprotection, anti-tumor, anti-viral, liver protection, hypoglycemic, and immunomodulatory. Since ginsenosides were first isolated from ginseng in 1963, their research has gradually deepened and has made significant progress in the field of modern Chinese medicine.
[0003] According to the relevant provisions of ICH Q3 C and the Chinese Pharmacopoeia 2020 Part IV 0861 Residual Solvent Determination Method, from the analysis of the synthesis process route and the properties of the materials themselves, the main residual solvents in ginsenosides include n-butanol, n-hexane and ethyl acetate. These residual organic solvents have adverse effects on human health. It is necessary to control their residual amounts within the limits specified by the Chinese Pharmacopoeia and ICH guidelines to ensure the quality of ginsenosides and thus ensure the safety of people's use of drugs. The current methods are unable to detect the above residual solvents at the same time, and the methods have poor accuracy and precision, poor separation, and low reproducibility. Summary of the invention
[0004] The purpose of the present invention is to provide a method for detecting residual solvents in ginsenosides to solve the problem of poor detection accuracy of residual solvents in ginsenosides.
[0005] The purpose of the present invention can be achieved by the following technical solutions:
[0006] A method for detecting residual solvents in ginsenosides comprises the following steps:
[0007] S1. Prepare reference solution and test solution:
[0008] Reference solution: accurately weigh appropriate amounts of n-butanol, n-hexane and ethyl acetate reference substances respectively, place them in a volumetric flask, add DMA (N,N-dimethylacetamide) to dissolve and quantitatively dilute to the scale, shake well, accurately measure an appropriate amount, and place it in a headspace bottle as the reference solution;
[0009] Test solution: Weigh an appropriate amount of ginsenoside production sample, accurately weigh it, place it in an empty bottle, add DMA to dissolve and mix well, and use it as the test solution;
[0010] S2. Perform headspace injection chromatographic analysis of the reference solution and the test solution by gas chromatography, and record the chromatogram;
[0011] S3. Conduct methodological verification and calculate the content by chromatographic peak area according to the external standard method. The content of n-hexane shall not exceed 290ppm; the content of n-butanol shall not exceed 5000ppm; and the content of ethyl acetate shall not exceed 5000ppm.
[0012] The calculation formula is formula 1:
[0013]
[0014] A Y ─Peak area of each solvent in the sample solution;
[0015] A S ─Peak area of each solvent in the reference solution;
[0016] C S - The concentration of each solvent in the reference solution;
[0017] C Y ─Concentration of sample solution.
[0018] As a further embodiment of the present invention, the gas chromatography conditions are:
[0019] Chromatographic column: DB-624 (60m×0.32mm, 1.8μm) or a chromatographic column with similar polarity;
[0020] Injection: headspace injection, headspace equilibrium temperature is 80-100℃, headspace equilibrium time is 28-32min;
[0021] Column temperature: programmed temperature, starting at 32°C-38°C, maintained for 12-14 min, then increased to 200°C at a rate of 12-18°C / min, maintained for 2 min;
[0022] Detector: FID detector, detector temperature is 230-270℃;
[0023] Inlet temperature: 180-220℃;
[0024] Flow rate: 1.2-1.8 mL / min;
[0025] Split ratio: 13-17:1;
[0026] Carrier gas: nitrogen;
[0027] Air flow rate: 380-420mL / min;
[0028] Hydrogen flow rate: 38-42 mL / min;
[0029] Tail nitrogen flow rate: 28-32mL / min;
[0030] Quantitative loop temperature: 90-100°C;
[0031] Transmission line temperature: 95-105°C;
[0032] Injection volume: 0.8-1.2mL;
[0033] Cycle time: 35min;
[0034] As a further embodiment of the present invention, the gas chromatography conditions are:
[0035] Chromatographic column: DB-624 (60m×0.32mm, 1.8μm) or a chromatographic column with similar polarity;
[0036] Injection: headspace injection, headspace equilibrium temperature is 90℃, headspace equilibrium time is 30min;
[0037] Column temperature: programmed temperature, starting at 35°C, maintained for 13 min, then increased to 200°C at a rate of 15°C / min, maintained for 2 min;
[0038] Detector: FID detector, detector temperature is 250℃;
[0039] Inlet temperature: 200°C;
[0040] Flow rate: 1.5 mL / min;
[0041] Split ratio: 15:1;
[0042] Carrier gas: nitrogen;
[0043] Air flow rate: 400mL / min;
[0044] Hydrogen flow rate: 40 mL / min;
[0045] Tail nitrogen flow rate: 30mL / min;
[0046] Quantitative loop temperature: 95°C;
[0047] Transmission line temperature: 100°C;
[0048] Injection volume: 1mL;
[0049] Cycle time: 35min.
[0050] As a further solution of the present invention, the reference solution is prepared specifically as follows:
[0051] Prepare reference stock solution: accurately weigh 1000 mg of n-butanol reference, 58 mg of n-hexane reference, and 1000 mg of ethyl acetate reference, and place them in a 100 mL volumetric flask to which 50 mL of DMA has been added, then dilute to the mark with DMA and shake well;
[0052] Prepare reference solution: accurately measure 5 mL of reference stock solution, place it in a 50 mL volumetric flask, dilute to the mark with DMA, and shake well; accurately measure 5 mL, place it in a 20 mL headspace bottle, and seal.
[0053] As a further solution of the present invention, the test solution is prepared specifically as follows:
[0054] Prepare the test solution: accurately weigh 1 g of ginsenoside production sample, place it in a 20 mL headspace bottle, add 5 mL of DMA to dissolve, mix well, and seal.
[0055] As a further aspect of the present invention, the methodological validation includes specificity, system suitability, detection limit, quantitation limit, linear range, accuracy, precision and robustness.
[0056] Compared with the prior art, the present invention has the following beneficial effects:
[0057] The present invention provides a method for detecting residual solvents in ginsenosides. The method adopts gas chromatography analysis to perform methodological verification on the residual solvents in ginsenosides. The method can sustainably and effectively detect three residual organic solvents in ginsenosides at the same time. The accuracy, precision, specificity, detection limit, quantitative limit, linearity and range, and durability meet the relevant requirements, thereby improving the detection efficiency, reducing the adverse effects caused by the residual solvents in the next production reaction, and improving the safety and effectiveness of the medicine. BRIEF DESCRIPTION OF THE DRAWINGS
[0058] The present invention will be further described below in conjunction with the accompanying drawings.
[0059] Figure 1 is a gas chromatogram of the test solution (SaS) in the present invention;
[0060] Figure 2 is a gas chromatogram of the spiked solution (SPS) in the present invention;
[0061] Figure 3 is a gas chromatogram of the reference solution (SS) in the present invention;
[0062] Figure 4 is the gas chromatogram of the blank solvent (Blank) in the present invention;
[0063] Figure 5 is a gas chromatogram of the ethyl acetate positioning solution (EA) in the present invention;
[0064] Figure 6 is a gas chromatogram of n-butanol solution (NBA) in the present invention;
[0065] Figure 7 is a gas chromatogram of the n-hexane positioning solution (n-hexance) in the present invention;
[0066] Figure 8 is a linear curve diagram of n-hexane in the present invention;
[0067] Fig. 9 is a linear curve diagram of ethyl acetate in the present invention;
[0068] Fig.10 It is a linear curve diagram of n-butanol in the present invention. DETAILED DESCRIPTION
[0069] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0070] A method for detecting residual solvents in ginsenosides comprises the following steps:
[0071] S1. Prepare reference solution and test solution:
[0072] Reference solution: accurately weigh appropriate amounts of n-butanol, n-hexane and ethyl acetate reference substances respectively, place them in a volumetric flask, add DMA to dissolve and quantitatively dilute to the scale, shake well, accurately measure an appropriate amount, and place it in a headspace bottle as the reference solution;
[0073] Test solution: Weigh an appropriate amount of ginsenoside production sample, accurately weigh it, place it in an empty bottle, add DMA to dissolve and mix well, and use it as the test solution;
[0074] S2. Perform headspace injection chromatographic analysis of the reference solution and the test solution by gas chromatography, and record the chromatogram;
[0075] The gas chromatography conditions were:
[0076] Chromatographic column: DB-624 (60m×0.32mm, 1.8μm) or a chromatographic column with similar polarity;
[0077] Injection: headspace injection, headspace equilibrium temperature is 80-100°C, headspace equilibrium time is 28-32min; preferably, headspace equilibrium temperature is 90°C, headspace equilibrium time is 30min;
[0078] Column temperature: programmed temperature, starting at 32°C-38°C, maintained for 12-14 min, then heated to 200°C at a rate of 12-18°C / min, maintained for 5 min; preferably, starting at 35°C, maintained for 13 min, then heated to 200°C at a rate of 15°C / min, maintained for 2 min;
[0079] Detector: FID detector, the detector temperature is 230-270°C; preferably, the detector temperature is 250°C;
[0080] Inlet temperature: 180-220°C; preferably, the inlet temperature is 200°C;
[0081] Flow rate: 1.2-1.8 mL / min; preferably, the flow rate is 1.5 mL / min;
[0082] Split ratio: 13-17:1; preferably, the split ratio is 15:1;
[0083] Carrier gas: nitrogen;
[0084] Air flow rate: 380-420 mL / min; preferably, the air flow rate is 400 mL / min;
[0085] Hydrogen flow rate: 38-42 mL / min; preferably, the hydrogen flow rate is 40 mL / min;
[0086] Tail blowing nitrogen flow rate: 28-32mL / min; preferably, the tail blowing nitrogen flow rate is 30mL / min;
[0087] Quantitative loop temperature: 90-100°C; preferably, the quantitative loop temperature is 95°C;
[0088] Transmission line temperature: 95-105°C; preferably, the transmission line temperature is 100°C;
[0089] Injection volume: 0.8-1.2 mL; preferably, the injection volume is 1 mL;
[0090] Cycle time: 35min;
[0091] S3. The content is calculated by the external standard method using the chromatographic peak area. The content of n-hexane shall not exceed 290 ppm, that of n-butanol shall not exceed 5000 ppm, and that of ethyl acetate shall not exceed 5000 ppm.
[0092] The calculation formula is formula 1:
[0093]
[0094] A Y─Peak area of each solvent in the sample solution;
[0095] A S ─Peak area of each solvent in the reference solution;
[0096] C S - The concentration of each solvent in the reference solution;
[0097] C Y ─Concentration of sample solution.
[0098] The technical solution of the present invention will be further described below in conjunction with specific embodiments; unless otherwise specified, the instruments, drugs, reagents, etc. used in the following embodiments can be obtained by conventional commercial means.
[0099] Gas chromatograph: Model 7890B / 7697A, manufactured by Agilent;
[0100] Electronic analytical balance: Model XPE205 / A or XPE205, produced by METTLER TOLEDO;
[0101] Solvent: N,N-dimethylacetamide (DMA), HPLC grade, purchased from Aladdin, batch number B2025102;
[0102] Reference substance: n-hexane, batch number W8QM1H-01, content 99.293%, validity period / retest period 2025.08.17;
[0103] Ethyl acetate: batch number C13876664-01, content 99.815%, expiration date / retest date 2024.04.29;
[0104] n-Butanol: batch number 20220218-011, content 99.9%, validity period / retest period 2027.02.17;
[0105] Sample: Ginsenosides.
[0106] Example 1
[0107] A method for detecting residual solvents in ginsenosides comprises the following steps:
[0108] S1. Prepare reference solution and test solution:
[0109] Prepare reference stock solution: accurately weigh 1000 mg of n-butanol reference, 58 mg of n-hexane reference, and 1000 mg of ethyl acetate reference, and place them in a 100 mL volumetric flask to which 50 mL of DMA has been added, then dilute to the mark with DMA and shake well;
[0110] Prepare reference solution: accurately measure 5 mL of reference stock solution, place it in a 50 mL volumetric flask, dilute to scale with DMA, and shake well; accurately measure 5 mL, place it in a 20 mL headspace bottle, and seal;
[0111] Prepare the test solution: accurately weigh 1 g of ginsenoside production sample, place it in a 20 mL headspace bottle, add 5 mL of DMA to dissolve, mix well, and seal.
[0112] S2. Perform headspace injection chromatographic analysis of the reference solution and the test solution by gas chromatography, and record the chromatogram;
[0113] The gas chromatography conditions were:
[0114] Chromatographic column: DB-624 (60m×0.32mm, 1.8μm) or a chromatographic column with similar polarity;
[0115] Injection: headspace injection, headspace equilibrium temperature is 90℃, headspace equilibrium time is 30min;
[0116] Column temperature: programmed temperature, starting at 35°C, maintained for 13 min, then increased to 200°C at a rate of 15°C / min, maintained for 2 min;
[0117] Detector: FID detector, detector temperature is 250℃;
[0118] Inlet temperature: 200°C;
[0119] Flow rate: 1.5 mL / min;
[0120] Split ratio: 15:1;
[0121] Carrier gas: nitrogen;
[0122] Air flow rate: 400mL / min;
[0123] Hydrogen flow rate: 40 mL / min;
[0124] Tail nitrogen flow rate: 30mL / min;
[0125] Quantitative loop temperature: 95°C;
[0126] Transmission line temperature: 100°C;
[0127] Injection volume: 1mL;
[0128] Cycle time: 35min;
[0129] S3. The content is calculated by the external standard method using the chromatographic peak area. The content of n-hexane (Class II solvent) shall not exceed 290 ppm, that of n-butanol (Class III solvent) shall not exceed 5000 ppm, and that of ethyl acetate (Class III solvent) shall not exceed 5000 ppm (according to the relevant provisions of ICH Q3C and the General Rules of the Fourth Volume of the Chinese Pharmacopoeia in 2020, Part 0861, Determination of Residual Solvents);
[0130] The calculation formula is formula 1:
[0131]
[0132] A Y ─Peak area of each solvent in the sample solution;
[0133] A S ─Peak area of each solvent in the reference solution;
[0134] C S - The concentration of each solvent in the reference solution;
[0135] C Y ─Concentration of sample solution.
[0136] Methodological validation:
[0137] The following method validation results on the specificity, system suitability, detection limit, quantification limit, linearity and range, accuracy, precision and robustness of the residual solvent detection in ginsenosides are summarized in Table 1:
[0138] Table 1
[0139]
[0140]
[0141]
[0142] (I) Specificity:
[0143] Accurately measure appropriate amounts of blank solvent (DMA), n-hexane positioning solution, ethyl acetate positioning solution, n-butanol positioning solution, reference solution, test solution and spiked solution, and measure them respectively according to the chromatographic conditions in S2, and record their respective chromatograms: the chromatograms of the test solution (SaS), spiked solution (SPS), reference solution (SS), blank solvent (Blank), ethyl acetate positioning solution (EA), n-butanol positioning solution (NBA), and n-hexane positioning solution (n-hexance) are as follows: Figure 1-7 As shown; the retention time (min) of different components in each sample and the separation of adjacent components were investigated, and the results of the spiked solution are shown in Table 2:
[0144] Table 2
[0145]
[0146] It can be seen from Table 2 that: (1) In the blank solvent chromatogram, there is no interfering peak at the peak position of the solvent to be tested, which meets the verification requirements;
[0147] (2) In the chromatograms of the reference solution and the spiked solution, the resolution of each solvent peak to be tested is greater than 1.5, meeting the validation requirements;
[0148] (3) The experimental results show that the blank solvent does not interfere with the determination of the solvents to be tested, the separation degree of the peaks of the solvents to be tested meets the requirements, and the specificity of this method is good.
[0149] (II) System applicability:
[0150] Accurately measure the reference solution, and inject 5 times continuously according to the chromatographic conditions in S2. Record the chromatogram and examine the peak areas and retention times of n-hexane, ethyl acetate and n-butanol in the reference solution. The results are shown in Table 3:
[0151] Table 3
[0152]
[0153] As shown in Table 3, the reference solution was injected 5 times continuously, and the relative standard deviations of the peak areas of n-hexane, ethyl acetate and n-butanol were all less than 10.0%, and the relative standard deviations of the retention times were all less than 1.0%, which met the verification requirements.
[0154] (III) Limit of quantification and detection limit:
[0155] Take appropriate amounts of the three reference substances, weigh them accurately, place them in a volumetric flask, dissolve them with DMA and quantitatively dilute them to a certain concentration, and then prepare solutions of different concentrations by gradually reducing the concentration. Determine them according to the chromatographic conditions in S2, and record the signal-to-noise ratio (S / N) of the chromatogram. When the signal-to-noise ratio is 3, calculate the concentration (μg / mL) at this time as the detection limit; when the signal-to-noise ratio is 10, calculate the concentration (μg / mL) at this time as the quantification limit, and dilute 6 times in the same way to examine the repeatability. The detection results of the detection limit are shown in Table 4, and the detection results of the quantification limit are shown in Tables 5-7:
[0156] Table 4
[0157]
[0158]
[0159] Table 5 (n-hexane)
[0160]
[0161] Table 6 (ethyl acetate)
[0162]
[0163] Table 7 (n-Butanol)
[0164]
[0165]
[0166] It can be seen from Tables 4 to 7 that: (1) In the detection limit solution, the signal-to-noise ratios of n-hexane, ethyl acetate, and n-butanol peaks are in the range of 3 to 10, which meets the verification requirements;
[0167] (2) The signal-to-noise ratios of the solvents to be tested in the six quantitative limit solutions were all within the range of 10 to 30, the relative standard deviations of the peak areas were all less than 10.0%, and the relative standard deviations of the retention times were all less than 1.0%, which met the verification requirements.
[0168] (IV) Linearity and range:
[0169] Take appropriate amount of 3 kinds of reference substances, weigh them accurately, and prepare reference substance solutions of 7 concentrations with DMA. For each reference substance, accurately measure the quantitative limit solution and the reference substance solutions of the above 7 concentrations, measure them according to the chromatographic conditions in S2, record the chromatogram, draw the standard curve with the concentration of the reference substance (mg / mL) as the horizontal axis and the corresponding peak area as the vertical axis, and fit the linear equation. The results are shown in Table 8 and Figure 8-Figure 10 shown.
[0170] Table 8
[0171]
[0172]
[0173] Figure 8 is the linear curve of n-hexane, Fig. 9 is the linear curve of ethyl acetate, Fig.10 is the linear curve of n-butanol; from Table 8 and Figure 8-Figure 10 It can be seen that: (1) n-hexane: In the concentration range of 0.000142 mg / mL to 0.1134 mg / mL, linear regression analysis was performed using concentration as the horizontal axis and peak area as the vertical axis. The correlation coefficient (r) of the regression equation was 0.9950, which was greater than 0.99. The response value of |Y-axis intercept| / 100% concentration was 6.9%, which was less than 25%. The RSD of the response factor was 7%, which was less than 10%, which met the verification requirements. The test results show that in the concentration range of 0.000142 mg / mL to 0.1134 mg / mL, the concentration of n-hexane has a linear relationship with the peak area, and the linear relationship is good.
[0174] (2) Ethyl acetate: In the concentration range of 0.001009 mg / mL to 2.0188 mg / mL, linear regression analysis was performed using concentration as the horizontal axis and peak area as the vertical axis. The correlation coefficient (r) of the regression equation was 0.9973, which was greater than 0.99. The response value of |Y-axis intercept| / 100% concentration was 2.2%, which was less than 25%. The RSD of the response factor was 3%, which was less than 10%, which met the verification requirements. The test results showed that in the concentration range of 0.001009 mg / mL to 2.0188 mg / mL, the concentration of ethyl acetate had a linear relationship with the peak area, and the linear relationship was good.
[0175] (3) n-Butanol: In the concentration range of 0.005013 mg / mL to 2.0054 mg / mL, linear regression analysis was performed using concentration as the abscissa and peak area as the ordinate. The correlation coefficient (r) of the regression equation was 0.9962, which was greater than 0.99. The response value of |Y-axis intercept| / 100% concentration was 2.6%, which was less than 25%. The RSD of the response factor was 4%, which was less than 10%, which met the verification requirements. The test results showed that in the concentration range of 0.005013 mg / mL to 2.0054 mg / mL, the concentration of ethyl acetate had a linear relationship with the peak area, and the linear relationship was good.
[0176] (V) Accuracy:
[0177] A certain amount of the reference substance of the tested component was accurately added to the test sample with a known content of the tested component, and its recovery rate was calculated. The results are shown in Table 9:
[0178] Table 9
[0179]
[0180]
[0181] As can be seen from Table 9, (1) at the three limits of 50%, 100% and 150%, the recoveries of n-hexane in 9 samples were 95.87% to 118.77%, with an average recovery of 110.77%; the recoveries of ethyl acetate were 90.26% to 106.16%, with an average recovery of 100.92%; the recoveries of n-butanol were 95.73% to 113.59%, with an average recovery of 102.55%, all within the range of 80.0% to 120.0%;
[0182] (2) The RSDs of the recoveries of n-hexane, ethyl acetate, and n-butanol were 6.6%, 5.9%, and 5.8%, respectively, all less than 10.0%, meeting the validation requirements;
[0183] (3) The experimental results show that this method has good accuracy in determining n-hexane, ethyl acetate and n-butanol.
[0184] (VI) Precision:
[0185] On different dates, 6 groups of spiked solutions of n-hexane, n-butanol, and ethyl acetate were prepared according to the preparation method in S1, and the samples were injected and tested according to the gas chromatography conditions in S2. The repeatability results are shown in Table 10, the intermediate precision results are shown in Table 11, and the precision results are shown in Table 12;
[0186] Table 10
[0187]
[0188] Table 11
[0189]
[0190]
[0191] Table 12
[0192]
[0193] As shown in Tables 10 to 12, (1) the RSDs of the n-hexane, ethyl acetate and n-butanol contents in each of the six solutions in the repeatability and intermediate precision tests were all less than 10.0%, which met the validation requirements. The test results showed that the method had good repeatability in determining n-hexane, ethyl acetate and n-butanol.
[0194] (2) The test solutions prepared by different personnel on different days were analyzed. The RSDs of the contents of n-hexane, ethyl acetate and n-butanol in the 12 solutions were all less than 15.0%, which was in line with the standard requirements. The test results showed that the precision of this method was good.
[0195] (VII) Durability:
[0196] A. Solution stability:
[0197] The reference solution and the spiked solution were sampled and tested at 0 hours, 6 hours, 12 hours, 25 hours, 35 hours, and 56 hours, respectively. The peak area, initial peak area, and their change values are shown in Table 13:
[0198] Table 13
[0199]
[0200] As shown in Table 13, the peak areas of n-hexane, ethyl acetate and n-butanol in the reference solution and the spiked solution placed at room temperature for 56 hours are less than 20% compared with the initial results, which are in line with the standard. The test results show that the reference solution and the spiked solution are basically stable within 56 hours at room temperature.
[0201] B. Durability of Chromatographic System:
[0202] The system suitability results of the chromatographic condition durability test are shown in Table 14; the determination results of each solvent in the chromatographic condition durability test are shown in Table 15;
[0203] Table 14
[0204]
[0205]
[0206] Table 15
[0207]
[0208] As can be seen from Tables 14 and 15, (1) the experimental results show that under each chromatographic condition, the separation between each solvent peak is greater than 1.5, which meets the system suitability requirements.
[0209] (2) The reference solution was injected 5 times continuously, and the relative standard deviations of the peak areas of n-hexane, ethyl acetate and n-butanol were all less than 10.0%, meeting the verification requirements;
[0210] (3) Under each chromatographic condition, the change values of n-hexane, ethyl acetate and n-butanol contents were all less than the 50% limit, meeting the verification requirements;
[0211] (4) In summary, the chromatographic system of this method has good durability.
[0212] The present invention uses gas chromatography analysis to perform methodological verification on the residual solvents in ginsenosides, has high detection accuracy, can sustainably and effectively detect three residual organic solvents in ginsenosides at the same time, and the accuracy, precision, specificity, detection limit, quantitative limit, linearity and range, and durability meet relevant requirements, thereby improving the detection efficiency, reducing the adverse effects caused by the residual solvents in the next production reaction, and improving the safety and effectiveness of the drug.
[0213] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprises" or any other variations thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device.
[0214] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A method for detecting residual solvents in ginsenosides, characterized in that: The following steps are involved: S1. Prepare reference solution and test solution: Reference solution: accurately weigh appropriate amounts of n-butanol, n-hexane and ethyl acetate reference substances respectively, place them in a volumetric flask, add DMA to dissolve and quantitatively dilute to the scale, shake well, accurately measure an appropriate amount, and place it in a headspace bottle as the reference solution; Test solution: Weigh an appropriate amount of ginsenoside production sample, accurately weigh it, place it in an empty bottle, add DMA to dissolve and mix well, and use it as the test solution; S2. Perform headspace injection chromatographic analysis of the reference solution and the test solution by gas chromatography, and record the chromatogram; S3. Perform methodological verification and calculate the contents of n-butanol, n-hexane and ethyl acetate using the chromatographic peak area according to the external standard method.
2. The method for detecting residual solvents in ginsenosides according to claim 1, characterized in that: The gas chromatography conditions in S2 are: Chromatographic column: DB-624 (60m×0.32mm, 1.8μm) or a chromatographic column with similar polarity; Injection: headspace injection, headspace equilibrium temperature is 80-100℃, headspace equilibrium time is 28-32min; Column temperature: programmed temperature, starting at 32°C-38°C, maintained for 12-14 min, then increased to 200°C at a rate of 12-18°C / min, maintained for 2 min; Detector: FID detector, detector temperature is 230-270℃; Inlet temperature: 180-220℃; Flow rate: 1.2-1.8 mL / min; Split ratio: 13-17:1; Carrier gas: nitrogen; Air flow rate: 380-420mL / min; Hydrogen flow rate: 38-42 mL / min; Tail nitrogen flow rate: 28-32mL / min; Quantitative loop temperature: 90-100°C; Transmission line temperature: 95-105°C; Injection volume: 0.8-1.2mL; Cycle time: 35min.
3. The method for detecting residual solvents in ginsenosides according to claim 2, characterized in that: The gas chromatography conditions are: Chromatographic column: DB-624 (60m×0.32mm, 1.8μm) or a chromatographic column with similar polarity; Injection: headspace injection, headspace equilibrium temperature is 90℃, headspace equilibrium time is 30min; Column temperature: programmed temperature, starting at 35°C, maintained for 13 min, then increased to 200°C at a rate of 15°C / min, maintained for 2 min; Detector: FID detector, detector temperature is 250℃; Inlet temperature: 200°C; Flow rate: 1.5 mL / min; Split ratio: 15:1; Carrier gas: nitrogen; Air flow rate: 400mL / min; Hydrogen flow rate: 40 mL / min; Tail nitrogen flow rate: 30mL / min; Quantitative loop temperature: 95°C; Transmission line temperature: 100°C; Injection volume: 1mL; Cycle time: 35min.
4. The method for detecting residual solvents in ginsenosides according to claim 1, characterized in that: The reference substance solution is prepared specifically as follows: Prepare reference stock solution: accurately weigh 1000 mg of n-butanol reference, 58 mg of n-hexane reference, and 1000 mg of ethyl acetate reference, and place them in a 100 mL volumetric flask to which 50 mL of DMA has been added, then dilute to the mark with DMA and shake well; Prepare reference solution: accurately measure 5 mL of reference stock solution, place it in a 50 mL volumetric flask, dilute to the mark with DMA, and shake well; accurately measure 5 mL, place it in a 20 mL headspace bottle, and seal.
5. The method for detecting residual solvents in ginsenosides according to claim 1, characterized in that: The test solution is prepared specifically as follows: Prepare the test solution: accurately weigh 1 g of ginsenoside production sample, place it in a 20 mL headspace bottle, add 5 mL of DMA to dissolve, mix well, and seal.
6. The method for detecting residual solvents in ginsenosides according to claim 1, characterized in that: The calculation formula for the contents of n-butanol, n-hexane and ethyl acetate in S3 is shown in Formula 1: A Y ─Peak area of each solvent in the sample solution; A S ─Peak area of each solvent in the reference solution; C S - The concentration of each solvent in the reference solution; C Y ─Concentration of sample solution.
7. The method for detecting residual solvents in ginsenosides according to claim 1, characterized in that: The methodological validation included specificity, system suitability, detection limit, quantitation limit, linear range, accuracy, precision and robustness.
